Compare Pfizer with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DISHMAN PHARMA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DISHMAN PHARMA PFIZER/
DISHMAN PHARMA
 
P/E (TTM) x 35.2 25.1 140.4% View Chart
P/BV x 6.0 3.3 180.2% View Chart
Dividend Yield % 0.6 0.7 85.3%  

Financials

 PFIZER   DISHMAN PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-19
DISHMAN PHARMA
Mar-16
PFIZER/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs3,840374 1,025.6%   
Low Rs2,080129 1,613.7%   
Sales per share (Unadj.) Rs455.0197.8 230.0%  
Earnings per share (Unadj.) Rs93.821.2 442.2%  
Cash flow per share (Unadj.) Rs109.434.7 315.0%  
Dividends per share (Unadj.) Rs22.502.00 1,125.0%  
Dividend yield (eoy) %0.80.8 95.6%  
Book value per share (Unadj.) Rs658.2179.9 365.9%  
Shares outstanding (eoy) m45.7580.69 56.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.51.3 511.4%   
Avg P/E ratio x31.611.9 266.0%  
P/CF ratio (eoy) x27.17.2 373.4%  
Price / Book Value ratio x4.51.4 321.5%  
Dividend payout %24.09.4 254.4%   
Avg Mkt Cap Rs m135,42020,306 666.9%   
No. of employees `0002.60.8 317.4%   
Total wages/salary Rs m3,2385,355 60.5%   
Avg. sales/employee Rs Th7,911.419,252.7 41.1%   
Avg. wages/employee Rs Th1,230.96,459.5 19.1%   
Avg. net profit/employee Rs Th1,630.72,064.1 79.0%   
INCOME DATA
Net Sales Rs m20,81515,961 130.4%  
Other income Rs m1,674265 630.7%   
Total revenues Rs m22,48916,226 138.6%   
Gross profit Rs m5,7124,103 139.2%  
Depreciation Rs m7141,091 65.5%   
Interest Rs m73944 7.7%   
Profit before tax Rs m6,5992,334 282.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,309624 370.2%   
Profit after tax Rs m4,2911,711 250.7%  
Gross profit margin %27.425.7 106.7%  
Effective tax rate %35.026.7 130.9%   
Net profit margin %20.610.7 192.3%  
BALANCE SHEET DATA
Current assets Rs m27,16711,018 246.6%   
Current liabilities Rs m8,9179,517 93.7%   
Net working cap to sales %87.79.4 932.3%  
Current ratio x3.01.2 263.2%  
Inventory Days Days68110 61.4%  
Debtors Days Days3035 86.4%  
Net fixed assets Rs m8,86216,304 54.4%   
Share capital Rs m458161 283.5%   
"Free" reserves Rs m29,65612,907 229.8%   
Net worth Rs m30,11314,516 207.5%   
Long term debt Rs m254,189 0.6%   
Total assets Rs m39,40029,805 132.2%  
Interest coverage x91.53.5 2,636.8%   
Debt to equity ratio x00.3 0.3%  
Sales to assets ratio x0.50.5 98.7%   
Return on assets %11.18.9 124.3%  
Return on equity %14.211.8 120.9%  
Return on capital %22.117.5 126.3%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m4284,952 8.6%   
Fx outflow Rs m786697 112.9%   
Net fx Rs m-3584,255 -8.4%   
CASH FLOW
From Operations Rs m9782,786 35.1%  
From Investments Rs m351-1,529 -23.0%  
From Financial Activity Rs m-1,099-941 116.7%  
Net Cashflow Rs m231316 72.9%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 3.7 202.7%  
FIIs % 4.9 12.7 38.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 22.1 107.2%  
Shareholders   85,207 46,261 184.2%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   TORRENT PHARMA  NATCO PHARMA  ELDER PHARMA  SANOFI INDIA  ALEMBIC PHARMA  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Crashes 1,203 Points; IT and Banking Stocks Witness Selling(Closing)

Indian share markets extended losses in the first trading session of FY21, as the number of coronavirus cases in the country continued to rise.

Related Views on News

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout...(The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Apr 1, 2020 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS